CA2708753A1 - Peptide servant d'agent diagnostique pour deceler la maladie de lyme - Google Patents
Peptide servant d'agent diagnostique pour deceler la maladie de lyme Download PDFInfo
- Publication number
- CA2708753A1 CA2708753A1 CA2708753A CA2708753A CA2708753A1 CA 2708753 A1 CA2708753 A1 CA 2708753A1 CA 2708753 A CA2708753 A CA 2708753A CA 2708753 A CA2708753 A CA 2708753A CA 2708753 A1 CA2708753 A1 CA 2708753A1
- Authority
- CA
- Canada
- Prior art keywords
- peptide
- seq
- peptides
- antibody
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne, par exemple, un peptide isolé qui comprend la série MKKNDQI(V ou G)AAIALRGVA (SEQ ID NO:64), où le peptide n'est pas plus long que 24 acides aminés et où le peptide peut se lier précisément à un anticorps introduit par un agent causal de la maladie de Lyme (une Borrelia pathologique), par exemple dans un échantillon prélevé d'un sujet atteint de la maladie de Lyme. Des versions de ce peptide comprennent, par exemple, la série MKKNDQIVAAIALRGVA (SEQ ID NO:65) ou MKKNDQIGAAIALRGVA (SEQ ID NO:66). Des peptides multimères linéaires sont également décrits et contiennent le peptide représenté par SEQ ID NO:64 ainsi qu'un épitope de peptide supplémentaire, ou plus, issu d'autres protéines de Borrelia qui peuvent également se lier précisément à un anticorps ci-dessus. Les compositions et les trousses de diagnostic qui comprennent un peptide ce cette invention sont décrites, tout comme les analyses diagnostiques qui utilisent le ou les peptides.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2708753A CA2708753C (fr) | 2010-06-25 | 2010-06-25 | Peptide servant d'agent diagnostique pour deceler la maladie de lyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2708753A CA2708753C (fr) | 2010-06-25 | 2010-06-25 | Peptide servant d'agent diagnostique pour deceler la maladie de lyme |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2708753A1 true CA2708753A1 (fr) | 2011-12-25 |
CA2708753C CA2708753C (fr) | 2014-02-18 |
Family
ID=45421237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2708753A Active CA2708753C (fr) | 2010-06-25 | 2010-06-25 | Peptide servant d'agent diagnostique pour deceler la maladie de lyme |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2708753C (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2809348A4 (fr) * | 2012-02-01 | 2016-01-06 | Biopeptides Corp | Peptides diagnostiques pour la maladie de lyme |
WO2017062535A2 (fr) | 2015-10-06 | 2017-04-13 | Bio-Rad Laboratories, Inc. | Dosages immunologiques de borrelia et matériaux associés |
US10006912B2 (en) * | 2013-12-06 | 2018-06-26 | Biopeptides Llc | Peptides for diagnosing lyme disease |
CN111727374A (zh) * | 2017-10-13 | 2020-09-29 | 纳米智能生物医学工程有限公司 | Grp78衍生肽用于鉴定高效干细胞 |
-
2010
- 2010-06-25 CA CA2708753A patent/CA2708753C/fr active Active
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2809348A4 (fr) * | 2012-02-01 | 2016-01-06 | Biopeptides Corp | Peptides diagnostiques pour la maladie de lyme |
US9816991B2 (en) | 2012-02-01 | 2017-11-14 | Biopeptides Corporation | Diagnostic peptides for lyme disease |
EP3447064A1 (fr) * | 2012-02-01 | 2019-02-27 | Biopeptides Corporation | Peptides de diagnostic pour la maladie de lyme |
US10006912B2 (en) * | 2013-12-06 | 2018-06-26 | Biopeptides Llc | Peptides for diagnosing lyme disease |
WO2017062535A2 (fr) | 2015-10-06 | 2017-04-13 | Bio-Rad Laboratories, Inc. | Dosages immunologiques de borrelia et matériaux associés |
EP3359558A4 (fr) * | 2015-10-06 | 2019-08-14 | Bio-rad Laboratories, Inc. | Dosages immunologiques de borrelia et matériaux associés |
US11209431B2 (en) | 2015-10-06 | 2021-12-28 | Bio-Rad Laboratories, Inc. | Borrelia immunoassays and materials therefor |
CN111727374A (zh) * | 2017-10-13 | 2020-09-29 | 纳米智能生物医学工程有限公司 | Grp78衍生肽用于鉴定高效干细胞 |
CN111727374B (zh) * | 2017-10-13 | 2024-02-20 | 纳米智能生物医学工程有限公司 | Grp78衍生肽用于鉴定高效干细胞 |
Also Published As
Publication number | Publication date |
---|---|
CA2708753C (fr) | 2014-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7887815B2 (en) | Peptide diagnostic agent for lyme disease | |
US11573227B2 (en) | Peptides and methods for the detection of Lyme disease antibodies | |
CA2781110C (fr) | Peptides et procedes pour la detection d'anticorps contre la maladie de lyme | |
EP2809348B1 (fr) | Peptides diagnostiques pour la maladie de lyme | |
CA2370493A1 (fr) | Peptides et analyses permettant de diagnostiquer la maladie de lyme et compositions utiles a la prevention de cette maladie | |
US8313915B2 (en) | Early detection of canine lyme disease by specific peptides and antibodies | |
CA2708753C (fr) | Peptide servant d'agent diagnostique pour deceler la maladie de lyme | |
US20150276739A1 (en) | Soluble treponema pallidum protein tp0453, tp0453-tp0326 fusion protein, and use in syphilis diagnosis | |
EP3077409B1 (fr) | Peptides destinés au diagnostic de la maladie de lyme | |
WO2010132758A2 (fr) | Test de diagnostic à base de ospc pour la maladie de lyme | |
US8338566B2 (en) | Characterization of BBK07 antigen of Borrelia burgdorferi and methods of use | |
Rauer et al. | Establishment of enzyme-linked immunosorbent assay using purified recombinant 83-kilodalton antigen of Borrelia burgdorferi sensu stricto and Borrelia afzelii for serodiagnosis of Lyme disease | |
WO2021211637A1 (fr) | Détection de la maladie de lyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |